- Issuer ticker
-
KURA
- Reported as of
-
23 Mar 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
25 Mar 2026, 09:00:03 UTC
Reporting owner
1 detail
- Reporting owner signature
-
Teresa Bair, Attorney-in-fact for Troy E. Wilson
Key filing fact
Troy E. Wilson filed Form 4 for Kura Oncology, Inc. (KURA) on 25 Mar 2026.
Key facts
- This page summarizes Troy E. Wilson's Form 4 filing for Kura Oncology, Inc. (KURA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 25 Mar 2026, 09:00.
Change
- Previous filing in this sequence was filed on 27 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001589597
Primary reporting owner
WILSON TROY EDWARD
- Relationship
-
President and CEO, Director
- Address
- C/O KURA ONCOLOGY, INC., 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO
- Signature
- Teresa Bair, Attorney-in-fact for Troy E. Wilson
- Signature date
- 25 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KURA
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +6,103
- Change %
- +1.4%
- Price
-
$6.15*
- Shares after
- 435,456
- Date
- 23 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
KURA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 279,194
- Date
- 23 Mar 2026
- Ownership
- by One Fish Two Fish Revocable Trust
KURA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 300,000
- Date
- 23 Mar 2026
- Ownership
- by Lorax Charitable Remainder Unitrust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KURA
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- +6,103
- Change %
- Price
-
$0.000000*
- Shares after
- 0
- Date
- 23 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,103
- Exercise price
- $6.15
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Explanation of responses
2 footnotes